On Dec. 5, 2025, an annual report published by the Institutes of Science and Development of the Chinese…
On Dec. 4, 2025, Merck Animal Health announced the U.S. Food and Drug Administration (FDA) has granted a…
On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
On Nov. 28, 2025, The Food and Drug Administration (FDA) announced the withdrawal of the proposed rule entitled…
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
On Nov. 19, 2025, researchers announced a Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
On Nov. 17, 2025, in a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute…
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…